2D and 3D QSAR of Benzimidazole Analogues as Novel HIV-1 Non Nucleoside Reverse Transcriptase Inhibitors
1, 1, 1, 1, 1, 1, 1
- 1Department of Pharmaceutical Chemistry, A.I.S.S.M.S. College of Pharmacy, Near RTO, Kennedy Road, Pune-411001, Maharashtra, INDIA.
CORRESPONDENCE
Shital Patil
Department of Pharmaceutical Chemistry, A.I.S.S.M.S. College of Pharmacy, Near RTO, Kennedy Road, Pune-411001, Maharashtra, INDIA.
Received: 12-12-2016; Accepted: 10-04-2017.
Volume 51, Issue 2s (Supplement) · pp. s122-s128 · 2017 · DOI: 10.5530/ijper.51.2s.58
ABSTRACT
Context: Acquired Immuno Deficiency Syndrome (AIDS) is a viral disease caused by Human Immunodeficiency Virus. There is an urgent need to identify newer NNRTIs active against these mutant strains Literature survey has revealed that N1-aryl-benzimidazole analogues have significant potential as HIV-1.Aim: Pharmacophore optimization of Benzimidazole nucleus as non-nucleoside reverse transcriptase inhibitors using Two Dimensional (2D) and Three Dimensional (3D) QSAR. Material & Method: Studies were carried out using V-Life MDS Softwre(4.3 version) using Multiple Linear Regression (MLR) Analysis and Simulated Annealing k Nearest Neighbor Molecular Field Analysis (SAkNN MFA). Result & Discussion: The model generated for 2D QSAR showed significant statistical parameters such as r2=0.8847, q2=0.7448. The model generated for 3D QSAR showed significant statistical parameter such as q2= of 0.6695.Conclusion: QSAR studies indicated the requirement of certain physicochemical parameters and hydrophobic groups for better Anti HIV activity.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Patil, S., Asgaonkar, K., Chitre, T., Bhat, V., Ethape, S., Sujalegaonkar, A., & Bhalekar, S. (2017). 2D and 3D QSAR of Benzimidazole Analogues as Novel HIV-1 Non Nucleoside Reverse Transcriptase Inhibitors. Indian Journal of Pharmaceutical Education and Research, 51(2s), s122-s128. https://doi.org/10.5530/ijper.51.2s.58
Copyright and licence
© 2017 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0